Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FDS PET/CT in Enterobacteriaceae Infections
NCT02450942Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of 18F-fluorodeoxysorbitol in Enterobacteriaceae infection, sponsored by Peking Union Medical College Hospital. Primary endpoint: Visual and semiquantitative assessment of lesions and biodistribution at 1 year. Status: unknown.
02
Drugs
18F-fluorodeoxysorbitol
03
Conditions
Enterobacteriaceae infection
Beyond the preview
Go deeper on NCT02450942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450942.